Displaying items by tag: institute for cancer outcomes and survivorship

Research led by UAB’s Institute for Cancer Outcomes and Survivorship finds that patients who received BMT using their own cells over the past three decades lived on average seven years fewer than peers, but newer strategies have narrowed the mortality gap.
Published in Research Findings

Smita Bhatia, M.D., has affected the lives of childhood cancer patients around the world, as well as many young researchers interested in following her path in survivorship and outcomes research, earning her selection for the academic medical center’s highest faculty honor.

Published in Awards & Honors

The largest registry of U.S. children with cancer who were diagnosed with COVID-19 found an increased risk of having severe infection and having their cancer therapy modified because of COVID, underscoring the urgency of vaccinations for these children, the authors say.

Published in Research Findings

Assistant Professor Noha Sharafeldin, MBBCh, Ph.D., presented cancer-related findings from the massive N3C database of records from COVID-positive patients at 55 institutions nationwide, including UAB. Results — including a significant increase in risk of death among patients who recently had chemotherapy — were published simultaneously in the Journal of Clinical Oncology.

Women who had total body irradiation to prepare for blood or marrow transplantation before age 30 had a 4.5-fold increase in their risk of developing breast cancer later in life.

UAB-led study finds that genetic variations associated with cognitive decline after BMT identify high-risk patients more accurately than current methods.

Noha Sharafeldin, MBBCh, Ph.D., of the Institute for Cancer Outcomes and Survivorship, used UAB’s supercomputer to identify biomarkers linked with cognitive impairment in patients who received a blood or marrow transplant. She’s also testing a way to repair the damage.